BPC-157 vs Bulevirtide
Overview
BPC-157 is primarily a healing & recovery peptide, while Bulevirtide is used for antiviral.
This page compares BPC-157 and Bulevirtide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| BPC-157 | Bulevirtide | |
|---|---|---|
| Category | Healing & Recovery | Antiviral |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | FDA approved |
| Typical dosage | 250-500 mcg | — |
| Frequency | daily | — |
| Reported benefits | Accelerated wound healing, tendon and ligament repair, gut health improvement, reduced inflammation, neuroprotective effects | — |
| Reported side effects | Generally well-tolerated. Rare: injection site reactions, mild fatigue | — |
Key differences
Primary use. BPC-157 is categorised under Healing & Recovery, while Bulevirtide falls under Antiviral. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. BPC-157: not FDA-approved; compounding permitted with a prescription as of April 2026. Bulevirtide: FDA-approved.
Dosing. BPC-157 is typically dosed at 250-500 mcg (daily). Typical dosing for Bulevirtide is not catalogued.
Can you stack them?
Some protocols combine peptides, but stacking BPC-157 and Bulevirtide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between BPC-157 and Bulevirtide?
- BPC-157 is primarily a healing & recovery peptide, while Bulevirtide is used for antiviral. BPC-157 is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Bulevirtide is FDA-approved for one or more indications.
- What is BPC-157 used for?
- Healing & recovery, gut health.
- What is Bulevirtide used for?
- First/only FDA-approved treatment for chronic hepatitis delta virus (HDV). FDA accelerated approval May 22, 2026. Brand: Hepcludex (Gilead).
- Can you take BPC-157 and Bulevirtide together?
- Some users combine peptides within a single protocol, but stacking BPC-157 and Bulevirtide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is BPC-157 or Bulevirtide FDA-approved?
- BPC-157 is not FDA-approved; compounding permitted with a prescription (as of April 2026). Bulevirtide is FDA-approved for one or more indications.
Read the full articles
- BPC-157 — full monograph: mechanism, research, dosing & references
- Bulevirtide — full monograph: mechanism, research, dosing & references